Brand-name Wegovy at $1,000 to $1,400 per month versus Peak Wellness at $149 per month on the annual plan means many patients simply cannot access brand-name versions
Regulation of glucose homeostasis by GLP-1
DPP-4 inhibitors (gliptins) should be stopped as not recommended together, as well as antimotility medications like codeine and loperamide
Effects of prebiotics on postprandial GLP-1, GLP-2 and glucose regulation in patients with type 2 diabetes: A randomised, double-blind, placebo-controlled crossover trial
Diabetic retinopathy in people with diabetes In semaglutide studies in diabetes, early worsening of diabetic retinopathy complications was observed, likely related to rapid glucose improvement rather than a direct drug effect
Drugs given concomitantly with narrow therapeutic windows should ensure monitoring is undertaken, especially at initiation of GLP-1 agonists when the effect is most pronounced